UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000005187 |
|---|---|
| Receipt number | R000006157 |
| Scientific Title | Establishment of the renal circulation measurement by PET |
| Date of disclosure of the study information | 2011/03/03 |
| Last modified on | 2011/03/03 21:54:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Establishment of the renal circulation measurement by PET
Acronym
Establishment of the renal circulation measurement by PET
Scientific Title
Establishment of the renal circulation measurement by PET
Scientific Title:Acronym
Establishment of the renal circulation measurement by PET
Region
| Japan |
Condition
Condition
Kidney disease
Classification by specialty
| Nephrology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To establish renal circulation using H215O PET in healthy subjects and patients with renal disease.
Basic objectives2
Others
Basic objectives -Others
To establish diagnostic methods.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Image and quantitative measurement of renal circulation
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with renal disease (Diabetes, Hypertension, Nephritis, acute kidney injury and contrast induced nephropathy
Key exclusion criteria
Subject with inappropriate usage of PET
Target sample size
25
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Takefumi Mori |
Organization
Tohoku University Graduate School of Medicine
Division name
Division of Nephrology, Endocrinology and Vascular Medicine
Zip code
Address
1-1 Seiryocho, Aoba-ku, Sendai 980-8574, Japan
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Tohoku University Graduate School of Medicine
Division name
Division of Nephrology, Endocrinology and Vascular Medicine
Zip code
Address
TEL
Homepage URL
tmori@med.tohoku.ac.jp
Sponsor or person
Institute
Tohoku University
Institute
Department
Personal name
Funding Source
Organization
Tohoku University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2011 | Year | 03 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2010 | Year | 10 | Month | 25 | Day |
Date of IRB
Anticipated trial start date
| 2011 | Year | 03 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Primary:Establish of renal circulation imaging
Secondary:Check adverse events
Renal circulation will be evaluated by H215O PET and compared between healthy subjects, patients with kidney disease, before and after hydration, before and after treatments.
Management information
Registered date
| 2011 | Year | 03 | Month | 03 | Day |
Last modified on
| 2011 | Year | 03 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006157
